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Objectives: Endovascular stent graft repair of abdominal aortic aneurysms (AAAs) prevents rupture by excluding the
aneurysm sac from systemic arterial pressure. Current surveillance protocols after endovascular aneurysm repair (EVAR)
follow secondary markers of sac pressurization, namely, endoleak and sac enlargement. We report the first clinical
experience with the use of a permanently implantable, ultrasound-activated remote pressure transducer to measure
intrasac pressure after EVAR.
Methods: Over 7 months, 14 patients underwent EVAR of an infrarenal abdominal aortic aneurysm with implantation of
an ultrasound-activated remote pressure transducer fixed to the outside of the stent graft and exposed to the excluded
aortic sac. Twelve patients received modular bifurcated stent grafts, and 2 patients received aortouniiliac devices. Intrasac
pressures were measured directly with an intravascular catheter and by the remote sensor at stent-graft deployment.
Follow-up sac pressures were measured with a remote sensor and correlated with systemic arterial pressure at every
follow-up visit. Mean follow-up was 2.6  1.9 months.
Results: Excellent concordance was found between catheter-derived and transducer-derived intrasac pressssure intraop-
eratively. Pulsatile waveforms were seen in all functioning transducers at each evaluation interval. One implant ceased to
function at 2 months of follow-up. In 1 patient a type I endoleak was diagnosed on 1-month computed tomography (CT)
scans; 3 type II endoleaks were observed. Those patients with complete exclusion of the aneurysm on CT scans had a
significant difference in systemic and sac systolic pressures initially (P < .001) and at 1 month (P < .001). Initial sac
diastolic pressures were higher than systemic diastolic pressures (P < .001). The ratio of systemic to sac systolic pressure
increased over time in those patients with complete aneurysm exclusion (P < .001). Four of 6 patients with no endoleak
and greater than 1-month follow-up had diminution of sac systolic pressure to 40 mm Hg or less by 3 months.
Conclusion: This is the first report of a totally implantable chronic pressure transducer to monitor the results of EVAR in
human beings. Aneurysm exclusion leads to gradual diminution of sac pressure over several months. Additional clinical
follow-up will be necessary to determine whether aneurysm sac pressure monitoring can replace CT in the long-term
surveillance of patients after EVAR. (J Vasc Surg 2004;40:405-12.)Since the initial report by Parodi et al1 in 1991, endo-
vascular stent graft repair of abdominal aortic aneurysms
(AAAs) has emerged as a potential alternative to traditional
open repair. Endovascular aneurysm repair (EVAR) has
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doi:10.1016/j.jvs.2004.06.027clear benefits in minimizing periprocedural morbidity and
potentially reducing mortality.2 Midterm results with sec-
ond-generation and third-generation devices have been
excellent.3 However, complications unique to endovascu-
lar repair have been identified. Perhaps the most significant
of these are endoleak and aneurysm sac expansion. Current
surveillance protocols after EVAR, whether computed to-
mography (CT), magnetic resonance imaging, or duplex
ultrasound scanning, are sensitive in enabling identification
of these secondary markers of sac pressurization. Much
work has been done, both in vitro and in animal models, to
characterize the changes in aneurysm sac pressurization
after EVAR.4-12 As yet no prospective studies have been405
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sure over time after EVAR in human beings.
We report the first clinical experience with the use of a
permanently implantable, ultrasound-activated remote pres-
sure transducer to measure intrasac pressure after EVAR.
METHODS
Since June 2003, 14 patients undergoing EVAR of an
infrarenal AAA were enrolled in this protocol. Twelve
patients received modular bifurcated devices, and 2 patients
received aortouniiliac devices. Mean preoperative aneurysm
size was 6.3 0.9 cm (range, 5.0-8.0 cm). Mean follow-up
was 2.6  1.9 months. This study was performed in con-
junction with our investigator-sponsored investigational
device exemption examining the use of the Talent endovas-
cular stent graft in the treatment of infrarenal AAAs in
patients at high risk. The expanded experimental protocol
and informed consent were approved by the US Food and
Drug Administration and the Institutional Review Board of
Mount Sinai School of Medicine. All subjects gave in-
formed consent.
Eligibility criteria. In brief, the Talent protocol is an
investigator-sponsored investigational device exemption
examining the use of the Talent-LPS endovascular stent
graft for repair of infrarenal AAAs in patients at high risk.
Patients must be deemed as at prohibitively high risk for
standard surgical therapy because of severe comorbid med-
ical illnesses. Anatomic criteria include a normal proximal
neck at least 1.5 cm long and a normal distal neck at least 1
cm long, with access vessels at least 8 mm in diameter.
Endovascular stent-graft description. The Talent-
LPS endovascular stent graft has been described.13 In brief,
this self-expanding endoprosthesis is composed of woven
polyester supported by nitinol Z-forms and a longitudinal
bar. The prosthesis is available in either an aortouniiliac or
modular bifurcated configuration. Deployment is by means
of manual retraction of the outer sheath. The outer diam-
eter ranges from 18F to 25F.
Device description. The Impressure AAA Sac Pres-
sure Transducer (Remon Medical) measures 3 mm 9 mm
 1.5 mm (Fig 1, A). It consists of a piezoelectric mem-
brane, which when actuated by ultrasound waves from a
hand-held probe charges a capacitor. Once charged, the
transducer measures ambient pressure, then generates an
ultrasound signal, which is relayed to the probe. The data
can then be downloaded and exported as an Excel data file
consisting of pressure measurements and the correspond-
ing times at which the measurements were taken. The
transducers were hand-sewn to the outside of the stent
graft, then repackaged in the delivery sheath. In patients
who received an aortouniiliac device, the transducer was
sewn to the graft approximately 6 cm below the attachment
system. No upsizing of the delivery system was necessary.
In patients who received a bifurcated device, the device was
sewn to the contralateral limb just below its exit from the
main body gate, and repackaged in a 20F delivery sheath
(Fig 1, B). This represents upsizing of the sheath from its
original 18F dimension.Deployment technique. The technique for stent-
graft deployment has been described.13 At stent-graft de-
ployment an intrasac catheter (5F Berenstein; Boston Sci-
entific) is placed in the excluded aneurysm. Simultaneous
catheter and ultrasound transducer pressures are obtained
in the operating room.
Follow-up. Follow-up, consisting of a physician office
visit, plain abdominal radiography, and 3-phase contrast
material–enhanced CT angiography was performed at 1, 6,
and 12 months, and yearly thereafter. Intrasac pressures
were obtained at every physician office visit (Fig 1, D). Both
translumbar and transabdominal approaches were used to
obtain pressure measurements. Systemic pressure was ob-
tained with a pressure cuff applied to the upper extremity.
Statistical analysis. Concordance between simulta-
neous pressure measurements was determined with the
Pearson correlation. Logistic regression analysis was used
to calculate the line of best fit for the scatterplots. Contin-
uous variables were compared with the paired Student t
test. Significance was assumed at P  .05.
RESULTS
Clinical success
In 13 of the 14 patients (93%) the aneurysm was
successfully excluded at the primary operation. In 1 patient
a distal type I endoleak with outflow through a patent
lumbar artery was diagnosed at 1-month follow-up, and
was successfully treated with an extension cuff. In this
patient a type II endoleak persisted. In 2 patients type II
endoleaks were noted on the 1-month CT scans, 1 from a
lumbar artery and 1 from a patent inferior mesenteric artery
(IMA) and paired lumbar arteries. The IMA endoleak was
persistent on the 6-month CT scan.
Technical success
We were unable to obtain simultaneous intraoperative
pressures in 4 patients. In 1 patient, small calcified iliac
arteries prevented passage of the iliac limb alongside the
intrasac catheter, and it was necessary to remove the in-
trasac catheter before device implantation. Two devices
demonstrated initial software problems, which were cor-
rected, enabling continued device function. In the fourth
patient we were unable to obtain intraoperative pressures
through an anterior transabdominal approach, because of
the patient’s body habitus. We were subsequently able to
obtain pressures through a translumbar approach once the
sterile drapes were removed.
Postoperatively we were successful in obtaining pres-
sures at every visit in all 14 patients. Interrogation of the
sensor in the office typically took 3 to 15 minutes. One
device ceased functioning at 2-month follow-up.
Initial concordance
The intraoperative concordance between transducer-
derived sac pressures and catheter-derived sac pressures was
excellent (Fig 2, A to C). The Pearson correlation coeffi-
JOURNAL OF VASCULAR SURGERY
Volume 40, Number 3 Ellozy et al 407Fig 1. A, Impressure abdominal aortic aneurysm sac pressure transducer (Remon Medical). B, Pressure transducer
sewn to contralateral limb of bifurcated Talent device. C, Digital subtraction angiogram shows distal type I endoleak
(arrow, pressure transducer). D, Transducing intrasac pressures in recovery room after surgery.
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0.97, and 0.96, respectively (P  .001).
Effect of increased abdominal pressure
Varying intra-abdominal pressure resulted in an ex-
pected variation in intrasac pressure measured with the
remote transducer in each patient. This was achieved by
Fig 2. Scatterplots demonstrate concordance between
A, Systolic pressure. B, Diastolic pressure. C, Pulse pr
available for 4 patients.having each patient perform the Valsalva maneuver during
transduction. This consistently raised the sac pressures by
approximately 15 mm Hg. Direct transcutaneous compres-
sion of the aneurysm sac during transduction raised the sac
pressure by approximately 20 to 30 mm Hg. These obser-
vations were used to confirm transducer function in the
postoperative period.
ac catheter and ultrasound transducer measurements.
. Simultaneous intraoperative measurements were notintras
essure
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Absence of type I endoleak. In patients with no type
I endoleak the initial sac systolic pressure was significantly
less than the systemic systolic pressure (P .001). Of note,
the initial sac diastolic pressure was greater than the sys-
temic diastolic pressure (P .001). The ratio of systemic to
sac systolic pressure increased from the time of implanta-
tion to 1-month follow-up (P  .001). In all patients at 1
month follow-up the sac systolic pressure was higher than
the systemic diastolic pressure (Table).
Of the 8 patients followed up for more than 1 month, 6
patients had no endoleak and 2 patients had type II en-
doleaks. In all 8 patients follow-up pressures were measured
at 3 months. The sac systolic pressure decreased to less than
the systemic diastolic pressure in 5 patients. Four of these 5
patients had no endoleak; in these 4 patients sac systolic
Fig 3. Pressure trends in a patient with completely ex
diastolic); dashed lines, sac pressure (systolic and diastoli
Systemic and sac pressures, initially and at 1 and 3 months
Patient Endoleak
Initial
Systemic
(mm Hg)
Sac
(mm Hg)
1 No 103/51 85/52
2 No 154/46 134/73
3 No 179/68 188/86
4 No 121/59 106/71
5 No 171/71 144/95
6 Type II 155/72 133/86
7 Type I 105/60 108/78
Type II*
8 No 174/81 120/96
9 No 151/70 145/105
10 No 155/66 140/82
11 Type II 162/63 128/68
12 No 126/72 89/57
13 No 127/52 93/71
14 No 134/42 106/62
*After repair of type I endoleak.
†Implant no longer transmitting pressure after 1-month follow-up.pressure decreased to 40 mm Hg or less at 3 months (Fig
3). The sixth and seventh patients, who had no evidence of
endoleak on CT scans, had systemic pressures of 135/78
mm Hg and 203/93 mm Hg, and sac pressures of 117/96
mm Hg and 151/104 mm Hg, respectively, at 3 months.
At the present time we have not determined the cause of the
increased sac pressures. An eighth patient, whose systemic
pressure was 137/83 mm Hg and sac pressure was 85/67
mm Hg at 5 months, was noted to have a type II endoleak
originating from a patent IMA and paired lumbar arteries
(Fig 4).
Presence of type I endoleak. One patient with a
bifurcated endograft had a distal type I endoleak on fol-
low-up cine–magnetic resonance angiography at 1 month.
Digital subtraction angiography was performed to better
delineate the leak. Systemic pressure at the time was
d aneurysm. Solid lines, Systemic pressure (systolic and
1 Month 3 Months
Systemic
(mm Hg)
Sac
(mm Hg)
Systemic
(mm Hg)
Sac
(mm Hg)
121/79 83/62 117/75 28/21
190/92 135/87
178/70 167/82 168/86 24/11
110/75 87/67 118/72 40/35
137/85 113/74
107/62 88/65 137/83 85/67
157/66 141/94
150/65* 106/77* 159/78* 88/65*
120/76 86/75 136/89 18/16
144/77 131/103 135/78 117/96
133/76 111/79
156/70 86/64
137/89 121/74 137/80
†
135/68 89/59
125/64 83/57 203/93 151/104clude
c).
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an intrasac catheter was 135/97 mm Hg, and the simulta-
neous ultrasound transducer–measured pressure was
141/94 mm Hg. This excellent correlation is also notable
in that the catheter was wedged in the endoleak approxi-
mately 7 cm from the transducer (Fig 1, C). In this patient
the type I endoleak was corrected with a distal cuff; how-
ever, there is a residual type II endoleak from a patent
lumbar artery (Fig 5). Three months after correction of the
type I endoleak systemic pressure is 147/72 mm Hg and
sac pressure is 52/40 mm Hg.
DISCUSSION
The determinants of sac pressure after EVAR are mul-
tifactorial. Patient-related factors include the presence or
absence of patent side branches, the nature of the aneurysm
thrombus, and the aneurysm anatomy.5-7 Device-related
factors include graft porosity, compliance, and pulsatility.4
A variety of experimental models have been used to exam-
Fig 4. Pressure trends in a patient with type II endoleak
lines, sac pressure (systolic and diastolic).
Fig 5. Pressure trends in a patient with type I endoleak
pressure (systolic and diastolic); dashed lines, sac pressurine the changes in sac pressure associated with EVAR. Early
in vivo work with a canine aneurysm model with a chronic
indwelling pressure transducer demonstrated that EVAR
significantly reduces sac pressures.4,5 Of note, the degree of
sac pressure reduction varied with the degree of graft
porosity. In vitro work with a canine AAA model demon-
strated that transmission of pressure to the aneurysm wall
depends on the nature of the sac contents.6 Specifically,
homogeneous thrombus appears to diminish transmission
of pressure, compared with unclotted whole blood. This
work also demonstrated that strain is not distributed uni-
formly to the wall of the aneurysm. This finding has been
corroborated in vivo at open aneurysm repair, before aortic
cross-clamping.7
The relationship of endoleak to sac pressure is less clear.
The work by Chong et al,8 who used a computer-generated
3-dimensional model of a real aneurysm cast in silicone,
demonstrated the complex relationship between endoleak
type, flow rates, and the resultant intrasac pressure. The
presence of a type I endoleak in this model led to systemic
d lines, Systemic pressure (systolic and diastolic); dashed
as corrected, now with type II leak. Solid lines, Systemic
tolic and diastolic). *Time of distal cuff placement.. Solithat w
e (sys
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sac pressure was a function of the inflow pressure. When a
type I endoleak was present in conjunction with outflow
from a patent side branch, increasing outflow lowered the
sac pressure. Others, using synthetic aneurysm models con-
nected to pulsatile pump systems, found that intrasac pres-
sure may be higher than systemic pressure in the presence of
endoleaks.9,10
This discrepancy in findings highlights the limitations
of experimental aneurysm models in mimicking what hap-
pens in human beings after EVAR. There have been few
studies in human beings that delineated long-term changes in
aneurysm sac pressure after EVAR. Using direct translumbar
puncture of the aneurysm sac, Sonesson et al11 demonstrated
that in patients with aneurysm exclusion and sac shrinkage
mean intrasac pressure diminished to 20% (range, 13%-33%)
of mean systemic pressure. Baum et al12 reported their retro-
spective analysis of sac pressures in 21 patients. In 4 patients
perioperative pressure measurements were obtained through a
catheter left in place alongside the stent graft. In 17 patients
the aneurysm sac was accessed at angiography to investigate an
endoleak demonstrated on the 1-month CT scan. These
authors noted elevated sac pressures in all of their patients. It
should be kept in mind that these patients were examined
early in the postoperative period, and our findings suggest that
it takes 3 to 6 months for aneurysm sac pressure to diminish to
the levels reported by Sonneson et al.11
Our results are consistent with much of what has
been shown in experimental models. Initially after EVAR
there is diminution in systolic pressure and a rise in
diastolic pressure in the sac. The cause of early diastolic
sac pressure elevation is uncertain. One potential expla-
nation is that a pulsatile graft in a fluid-filled sac with
little outflow will prevent decompression of the sac in
diastole. What is clear, however, is that sac pressures
evolve gradually, which suggests that thrombus matura-
tion and changes in graft porosity may have a role in
pressure diminution over time. The sac pressure in the 3
patients with type II endoleaks decreased over time, yet
not so strikingly as in those patients with no endoleaks.
In 4 of 6 patients with no endoleak and more than
1-month follow-up sac pressure was reduced to less than
30% of systemic pressure by 3 months. Further follow-up
is necessary in the 2 patients without endoleaks who had
elevated sac pressures at 3 months. Whether this was the
result of endotension has yet to be determined.
Regarding the issue of sac pressure compartmental-
ization, an interesting finding was noted in the patient
with the type I endoleak. Pressures obtained at the origin
of the endoleak were equivalent to pressures obtained by
the transducer fixed to the device, approximately 7 cm
away. While there are limitations to the accuracy of a
hydrostatic column pressure transducer (such as the
end-hole catheter) wedged in thrombus, the similarity in
pressure readings is striking. Experimental work has
demonstrated that in the excluded aneurysm with
thrombus sac pressure is greatest closest to the graft.6The design of our study, with only 1 transducer im-
planted in each patient, does not enable us to properly
answer the question of sac compartmentalization. How-
ever, the fact that pressures measured immediately adja-
cent to the graft diminished suggests that a single trans-
ducer may be adequate in surveillance of sac pressures.
CONCLUSION
Chronic, noninvasive sac pressure transduction after
EVAR is feasible. Complete aneurysm exclusion can be
expected to result in considerable pressure reduction in the
aneurysm sac. Further follow-up is needed to delineate the
long-term sac pressures in patients with type II endoleaks.
Noninvasive pressure transduction shows great promise in
the future surveillance of patients after EVAR.
REFERENCES
1. Parodi JC, Palmaz JC, Barone HD. Transfemoral intraluminal graft
implantation for abdominal aortic aneurysms. Ann Vasc Surg 1991;5:
491-9.
2. Anderson PL, Arons RR, Moskowitz AJ, Gelijns A, Magnell C, Faries
PL, et al. A statewide experience with endovascular abdominal aortic
aneurysm repair: rapid diffusion with excellent early results. J Vasc Surg
2004;39:10-9.
3. Marin ML, Hollier LH, Ellozy SH, Spielvogel D, Mitty H, Griepp R, et
al. Endovascular stent graft repair of abdominal and thoracic aortic
aneurysms: a ten-year experience with 817 patients. Ann Surg 2003;
238:586-93; discussion 593-5.
4. Faries PL, Sanchez LA, Marin ML, Parsons RE, Lyon RT, Oliveri S, et
al. An experimental model for the acute and chronic evaluation of
intra-aneurysmal pressure. J Endovasc Surg 1997;4:290-7.
5. Sanchez LA, Faries PL, Marin ML, Ohki T, Parsons RE, Marty B, et al.
Chronic intra-aneurysmal pressure measurement: an experimental
method for evaluating the effectiveness of endovascular aortic aneurysm
exclusion. J Vasc Surg 1997;26:222-30.
6. Pacanowski JP, Stevens SL, Freeman MB, Dieter RS, Klosterman LA,
Kirkpatrick SS, et al. Endotension distribution and the role of thrombus
following endovascular AAA exclusion. J Endovasc Ther 2002;9:639-
51.
7. Vallabhaneni SR, Gilling-Smith GL, Brennan JA, Heyes RR, Hunt JA,
How TV, et al. Can intrasac pressure monitoring reliably predict failure
of endovascular aneurysm repair? J Endovasc Ther 2003;10:524-30.
8. Chong CK, How TV, Gilling-Smith GL, Harris PL. Modeling en-
doleaks and collateral reperfusion following endovascular AAA exclu-
sion. J Endovasc Ther 2003;10:424-32.
9. Parodi JC, Berguer R, Ferreira LM, La Mura R, Schermerhorn ML.
Intra-aneurysmal pressure after incomplete endovascular exclusion. J
Vasc Surg 2001;34:909-14.
10. Mehta M, Veith FJ, Ohki T, Lipsitz EC, Cayne NS, Darling RC III.
Significance of endotension, endoleak, and aneurysm pulsatility after
endovascular repair. J Vasc Surg 2003;37:842-6.
11. Sonesson B, Dias N, Malina M, Olofsson P, Griffin D, Lindblad B, et al.
Intra-aneurysm pressure measurements in successfully excluded ab-
dominal aortic aneurysm after endovascular repair. J Vasc Surg 2003;
37:733-8.
12. Baum RA, Carpenter JP, Cope C, Golden MA, Velazquez OC, Neschis
DG, et al. Aneurysm sac pressure measurements after endovascular
repair of abdominal aortic aneurysms. J Vasc Surg 2001;33:32-41.
13. Faries PL, Brener BJ, Connelly TL, Katzen BT, Briggs VL, Burks JA Jr,
et al. A multicenter experience with the Talent endovascular graft for
the treatment of abdominal aortic aneurysms. J Vasc Surg 2002;35:
1123-8.
Submitted Jan 13, 2004; accepted Jun 20, 2004.
JOURNAL OF VASCULAR SURGERY
September 2004412 Ellozy et alDISCUSSIONDr Samuel Money (New Orleans, La). The idea of develop-
ing a device that can sense intrasac pressure is one we all have been
hoping for. This device is of a marvelous design. It’s marvelous in
that with its small size it can measure intrasac pressure after being
activated by ultrasound. I have but 3 basic questions.
What do the numbers that it generates mean? I reviewed your paper
and cannot tell, based on the intrasac pressure, what is going on with the
aneurysm. Is the aneurysm expanding, is it stable, or is it contracting? Is it
possible that it is too early to know what the individual numbers mean?
You refer to sac systolic pressure to systemic diastolic pressure. Is that the
number that seems to be the most appropriate to follow?
The second question is one that was thought up with a
different device, that is, whether the device gets covered by throm-
bus or some intimal hyperplasia and stops functioning correctly.
Another way to ask that is whether your long-term follow-up
values are similar to the values you get in the beginning, or are they
reflecting different states?
The third question is the easiest one to answer. How much
do these devices cost, how much does it cost to get a pressure
reading, and how much is the special equipment needed to use
them?
I think this is a device that is truly going to affect what goes on
in our treatment of aneurysms.
Dr Sharif H. Ellozy. I am going to answer your question
with regard to the validity of the numbers over time. One of the
phenomena that our physician’s assistant noted, and I am grateful
to him for this, is that when you increase intra-abdominal pressure
by either having the patient perform the Valsalva maneuver or by
directly compressing the aneurysm sac you could induce an eleva-
tion in the sac pressure. With compression you can increase it by
about 20 to 30 mm, and with the Valsalva maneuver by about 15
mm. We use this as an internal control to make sure the devices are
working, so when we measure pressure in these patients 6 months
out we then do this. If the sac pressure is 10 mm Hg and we are able
to elevate it to 30 mm Hg, we get the sense that this is a real
pressure measurement and not simply one that is damped because
the transducer is surrounded by thrombus. This is a phenomenon
that we found reproducible in all of our patients.
With regard to what the numbers mean, they characterize the
patients with no endoleak. As I mentioned, there were 4 of 5 patients
whose sac pressures diminished to less than 40 mm Hg at 3-month
follow-up. We had 1 patient who had persistent elevation of pressures,
and I did not discuss this fully, but this is a sagittal reconstruction from
the CT angiogram. You can see here that the patient had a preoper-
ative left renal artery stent placed. The stent graft goes all the way up
to the renal artery, so it is as proximal as possible; however, we see that
there is somethrombusaroundtheneck.Wehadoriginally sized it for the
neck farther down, but I do not think it is fully deployed. It may be
because it is constrained proximally, and my suspicion is that this patient,
although he has no endoleak noted, has transmission of pressure through
the thrombus. It will be interesting to see what happens with pressure
over time, and I think that the patient is going to require either a largeballoon-expandable stent to try to coapt this wall better, or open conver-
sion.
With regard to your third question, it is a private company that
produces this. I do not know what the ultimate cost will be. There is
probably an up-front cost on the order of $1000 to $2000. However,
if this does ultimately lead to better surveillance, you may forego the
cost of yearly CT scans, and the surgeon can bill for insonating the
device in the office. That is just something to keep in mind.
Dr Charles Sternbergh (New Orleans, La). Your final com-
ments are a perfect segue to my question regarding long-term surveil-
lance. In the abstract you hypothesize that perhaps intrasac pressure
measurements could replace CT scanning for surveillance in the
future. I have significant concerns about that conclusion. The diffi-
culty with that concept is that you must wait until a late type I or III
leak occurs before a potential intervention can be performed. All
devices demonstrate some degree of migration. It may vary between
devices, but all devices can migrate, and it is clear with some devices an
existing endoleak does not predict subsequent rupture. However,
so-called insecure fixation has been noted retrospectively to be appar-
ent in many patients in whom the aneurysm has gone on to rupture.
Are you really comfortable with the concept of just watching for
changes in intrasac pressure? Don’t you want to monitor for migra-
tion of the device?
Dr Ellozy. That’s a very good question. One of the things we
can do to look for migration is 4-view plain films of the abdomen.
The other thing is, these are very preliminary data. We are still
finding out what the pressure means, so by no means do I suggest
that we are ready to do this yet. However, I think with longitudinal
follow-up we may find that this is a useful tool in surveillance.
Dr Sternbergh. I do not think that many people here would
think that plain KUBs, no matter how many views you take, are
going to be useful in measuring anything but very, very large
degrees of migration.
Dr Mitchell Goldman (Knoxville, Tenn). First, I congratulate you
onconfirmingwhatwehavenoticed in the laboratory,which is essentially
3 principles. One, when you do completely exclude the aneurysm you do
get diminution of sac pressure. Two, with possible endotension you get
persistent rise in sacpressure.Three,whenyouhavea type1endoleakyou
get systemic pressure. This is a phenomenal corroboration of what has
been seen in the laboratory and taken to the clinical venue.
My question is, have you actually in that patient done an
arteriogram and looked for any runoff, because if you postulate
that you do have endotension there may be some indication that
you have irregularity at the attachment site.
DrEllozy.Atour institution,oneofour radiologistshasgottena lot
ofexperiencewithendoleaksandendotension. In thosepatients inwhom
we do not find endoleak on CT scans or angiograms, they do an MR
sequence called a true FISP, and it is able to differentiate between liquid
and organized thrombus. We have found that in our patients with
endotension, enlarging sacs with no evidence of endoleak, they show up
as liquid on this true FISP sequence. So this patient is actually going to be
brought in foranMRwiththis sequence. If it is indeterminate, thepatient
is going to undergo angiography.
